Duloxetine
Product Images NDC 50090-6040

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-6040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetinedraddress1 (Duloxetinedraddress1)

FDA Label Image

Duloxetinedraddress2 (Duloxetinedraddress2)

FDA Label Image

Duloxetinedrfigure1 (Duloxetinedrfigure1)

FDA Label Image

Duloxetinedrfigure2 (Duloxetinedrfigure2)

This is a graph that shows the proportion of patients with relapse over time from randomization, measured in days. The graph displays a decrease in the proportion of patients experiencing relapse as time passes.*

FDA Label Image

Duloxetinedrfigure3 (Duloxetinedrfigure3)

This is a graph illustrating the percentage of patients who experienced an improvement in pain based on four different treatment approaches: Duloxetine 60mg BID, Duloxetine 60mg OD, Duloxetine 20mg OD, and Placebo. The horizontal axis shows the percent improvement in pain from baseline, while the vertical axis shows the number of patients. The graph shows a peak at 100% improvement, indicating that the treatment approach effectively reduced the pain in a significant number of patients.*

FDA Label Image

Duloxetinedrfigure4 (Duloxetinedrfigure4)

FDA Label Image

Duloxetinedrfigure7 (Duloxetinedrfigure7)

FDA Label Image

Duloxetinedrfigure8 (Duloxetinedrfigure8)

The text does not provide enough information to generate a useful description. It seems to be some kind of data table, but without a clear context or labels it is not possible to provide any relevant information.*

FDA Label Image

Duloxetinedrfigure9 (Duloxetinedrfigure9)

This text shows a chart indicating the percentage of patients who experienced improvement in pain from baseline, with Dulcseiass120 and a placebo being compared. The percentage of patients who improved with Dulcseiass120 is not provided in this chart.*

FDA Label Image

Duloxetinedrstructure (Duloxetinedrstructure)

FDA Label Image

Label Image (Lbl500906040)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.